Regentatlantic Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 3,798 shares of REGN stock, worth $2.83 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,798

Previous 3,705 2.51%

Holding current value

$2.83 Million

Previous $2.19 Million 19.45%

% of portfolio

0.08%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $53,379 - $67,361	93 Added 2.51%	3,798 $2.62 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $91,026 - $122,647	-166 Reduced 4.29%	3,705 $2.19 Million
Q1 2022 May 02, 2022	BUY	$595.12 - $698.43 $52,965 - $62,160	89 Added 2.35%	3,871 $2.7 Million
Q4 2021 Jan 27, 2022	BUY	$543.48 - $670.97 $7,065 - $8,722	13 Added 0.34%	3,782 $2.39 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $339,251 - $402,447	-591 Reduced 13.56%	3,769 $2.28 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $453,888 - $536,198	-960 Reduced 18.05%	4,360 $2.44 Million
Q1 2021 Apr 29, 2021	SELL	$446.73 - $548.2 $531,161 - $651,809	-1,189 Reduced 18.27%	5,320 $2.52 Million
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $2.95 Million - $3.75 Million	-6,170 Reduced 48.66%	6,509 $3.15 Million
Q3 2020 Oct 13, 2020	BUY	$544.75 - $658.21 $3.33 Million - $4.03 Million	6,121 Added 93.34%	12,679 $7.1 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.76 Million - $3.6 Million	5,590 Added 577.48%	6,558 $4.09 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $64,882 - $95,424	193 Added 24.9%	968 $473,000
Q4 2019 Feb 04, 2020	BUY	$274.13 - $376.51 $212,450 - $291,795	775 New	775 $291,000
Q2 2019 Jul 23, 2019	SELL	$299.6 - $414.82 $159,387 - $220,684	-532 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$372.08 - $439.57 $4,464 - $5,274	-12 Reduced 2.21%	532 $218,000
Q4 2018 Jan 30, 2019	BUY	$335.82 - $403.04 $4,029 - $4,836	12 Added 2.26%	544 $203,000
Q3 2018 Oct 30, 2018	SELL	$351.14 - $408.51 $35,114 - $40,851	-100 Reduced 15.82%	532 $215,000
Q1 2018 Apr 23, 2018	BUY	$315.82 - $393.78 $18,949 - $23,626	60 Added 10.49%	632 $218,000
Q4 2017 Jan 23, 2018	BUY	$358.63 - $469.95 $12,552 - $16,448	35 Added 6.52%	572 $215,000
Q3 2017 Oct 25, 2017	BUY	$431.38 - $504.0 $231,651 - $270,648	537	537 $240,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History